HLA‐A ∗ 01:01 Allele Is Associated With Increased Risk of Transplant‐Related Mortality After MHC Matched Unmodified Allogeneic Hematopoietic Stem Cell Transplantation
Journal of Immunology Research · 2026
DOI: 10.1155/jimr/7237488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2026. Verfasst von Emily A Cowen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Graft vs Host Disease, Alleles, HLA-A Antigens. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH/NCI Cancer Center.
Abstract (Originalsprache)
Acute graft‐versus‐host disease (aGvHD) remains a substantial cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (allo‐HCT). Limited studies explore the association between specific major histocompatibility complex (MHC) alleles and aGvHD or transplant‐related mortality (TRM). After a noted clinical trend of higher TRM among a series of patients with aGvHD and MHC class I HLA‐01:01, we retrospectively evaluated transplant outcomes of 404 adult allo‐HCT patients who underwent unmodified allografts between 03/2010 and 02/2017. HLA‐01:01 was expressed by 104 (25.7%) patients. In a univariate analysis, patients who underwent unmodified transplants and expressed HLA‐01:01 had a higher risk of TRM (HR 1.63 [95% CI: 1.05–2.53], p = 0.035). In a multivariate cause‐specific Cox model, HLA‐01:01 was significantly associated with TRM after adjusting for grade II–IV aGvHD, conditioning regimen intensity, and age at transplant (HR 1.59 (95% CI: 1.02–2.48) p = 0.039). There were no significant differences in overall survival (OS), aGvHD, or chronic GvHD based on HLA‐01:01 expression. With confirmation in a larger cohort, these findings have potential implications for the selection of allograft type, conditioning regimen, and post‐transplant monitoring for this high‐risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.
- Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.
- Department of Dermatology, Weill Cornell Medical College, New York, New York, USA, cornell.edu.
- Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.
ORCID-Profile: Emily A Cowen, Samantha Brown, Rachel E Reingold, Sarah Samorodnitsky, Sean M Devlin, James W Young, Molly Maloy, Sergio Giralt, Doris M Ponce, Alina Markova
Förderung
- NCI NIH HHS
- NIH/NCI Cancer Center
Zitieren
APA
Cowen, E. A., Brown, S., Reingold, R. E., Samorodnitsky, S., Fonseca, M., Stoll, J. R., Devlin, S. M., Young, J. W., Fatmi, S. A., Maloy, M., Giralt, S., Ponce, D. M., Jakubowski, A. A., & Markova, A. (2026). HLA‐A ∗ 01:01 Allele Is Associated With Increased Risk of Transplant‐Related Mortality After MHC Matched Unmodified Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Immunology Research. https://doi.org/10.1155/jimr/7237488
Vancouver
Cowen EA, Brown S, Reingold RE, Samorodnitsky S, Fonseca M, Stoll JR, et al. HLA‐A ∗ 01:01 Allele Is Associated With Increased Risk of Transplant‐Related Mortality After MHC Matched Unmodified Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Immunology Research. 2026. doi:10.1155/jimr/7237488
BibTeX
@article{Cowen2026,
author = {Cowen, Emily A and Brown, Samantha and Reingold, Rachel E and Samorodnitsky, Sarah and Fonseca, Maira and Stoll, Joseph R and Devlin, Sean M and Young, James W and Fatmi, Samira A and Maloy, Molly and Giralt, Sergio and Ponce, Doris M and Jakubowski, Ann A and Markova, Alina},
title = {HLA‐A ∗ 01:01 Allele Is Associated With Increased Risk of Transplant‐Related Mortality After MHC Matched Unmodified Allogeneic Hematopoietic Stem Cell Transplantation},
journal = {Journal of Immunology Research},
year = {2026},
doi = {10.1155/jimr/7237488}
}
EUVIMED